<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Atlas 2 -- Foundation models for clinical deployment - Health AI Hub</title>
    <meta name="description" content="This paper introduces Atlas 2, Atlas 2-B, and Atlas 2-S, a new family of pathology vision foundation models designed to overcome existing tradeoffs in performan">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Atlas 2 -- Foundation models for clinical deployment</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.05148v1" target="_blank">2601.05148v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-08
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Maximilian Alber, Timo Milbich, Alexandra Carpen-Amarie, Stephan Tietz, Jonas Dippel, Lukas Muttenthaler, Beatriz Perez Cancer, Alessandro Benetti, Panos Korfiatis, Elias Eulig, J√©r√¥me L√ºscher, Jiasen Wu, Sayed Abid Hashimi, Gabriel Dernbach, Simon Schallenberg, Neelay Shah, Moritz Kr√ºgener, Aniruddh Jammoria, Jake Matras, Patrick Duffy, Matt Redlon, Philipp Jurmeister, David Horst, Lukas Ruff, Klaus-Robert M√ºller, Frederick Klauschen, Andrew Norgan
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.05148v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.05148v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces Atlas 2, Atlas 2-B, and Atlas 2-S, a new family of pathology vision foundation models designed to overcome existing tradeoffs in performance, robustness, and computational requirements that previously limited clinical deployment. Trained on the largest pathology foundation model dataset to date (5.5 million histopathology whole slide images), these models achieved state-of-the-art performance across eighty public benchmarks, paving the way for practical clinical integration.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>These foundation models significantly enhance the reliability and efficiency of AI tools in pathology, promising improved diagnostic accuracy, more robust analyses across diverse patient populations, and practical integration into clinical workflows for enhanced patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>These pathology vision foundation models are designed to analyze histopathology whole slide images to assist and improve medical diagnosis within the field of pathology. Their intended 'clinical deployment' means they would be used by clinicians to enhance diagnostic accuracy, efficiency, and robustness in healthcare settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical limitations of prior pathology foundation models, specifically regarding performance, robustness, and computational resource efficiency.</li>
                    
                    <li>Introduces three distinct pathology vision foundation models: Atlas 2, Atlas 2-B, and Atlas 2-S, tailored for clinical deployment.</li>
                    
                    <li>Achieved state-of-the-art (SOTA) performance across all assessed metrics: prediction accuracy, robustness, and resource efficiency.</li>
                    
                    <li>Trained on an unprecedented dataset of 5.5 million histopathology whole slide images (WSIs), making it the largest pathology foundation model dataset.</li>
                    
                    <li>Data for training was sourced from three leading medical institutions: Charit√© - Universt√§tsmedizin Berlin, LMU Munich, and Mayo Clinic, ensuring diverse data representation.</li>
                    
                    <li>The models' capabilities were rigorously evaluated through a comprehensive assessment across eighty distinct public benchmarks.</li>
                    
                    <li>Designed to bridge the gap between advanced computational pathology research and real-world clinical application, facilitating broader clinical deployment.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved training three pathology vision foundation models (Atlas 2, Atlas 2-B, Atlas 2-S) on an extensive dataset comprising 5.5 million histopathology whole slide images. This large-scale dataset was aggregated from three major medical institutions. Model performance, robustness, and resource efficiency were then comprehensively evaluated against eighty public benchmarks to demonstrate their state-of-the-art capabilities.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The Atlas 2 model family (Atlas 2, Atlas 2-B, Atlas 2-S) achieved state-of-the-art performance in prediction accuracy, robustness, and computational resource efficiency. This directly addresses and overcomes the key shortcomings that previously hindered the clinical deployment of pathology foundation models.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By delivering highly robust, efficient, and top-performing models, Atlas 2 significantly accelerates the readiness of computational pathology for practical clinical integration. This has the potential to lead to faster, more accurate diagnoses, personalized treatment strategies, and improved patient outcomes by providing clinicians with dependable AI-powered tools.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The provided abstract does not explicitly state any limitations specific to the Atlas 2 models themselves. It focuses on how these new models overcome the limitations of previous pathology foundation models.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly outline future research directions. Its primary focus is on the models' current state-of-the-art performance and their immediate potential for clinical deployment.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Digital Pathology</span>
                    
                    <span class="tag">Diagnostic Medicine</span>
                    
                    <span class="tag">Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">pathology foundation models</span>
                    
                    <span class="tag tag-keyword">computational pathology</span>
                    
                    <span class="tag tag-keyword">histopathology</span>
                    
                    <span class="tag tag-keyword">whole slide imaging</span>
                    
                    <span class="tag tag-keyword">clinical deployment</span>
                    
                    <span class="tag tag-keyword">AI robustness</span>
                    
                    <span class="tag tag-keyword">resource efficiency</span>
                    
                    <span class="tag tag-keyword">deep learning</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Pathology foundation models substantially advanced the possibilities in computational pathology -- yet tradeoffs in terms of performance, robustness, and computational requirements remained, which limited their clinical deployment. In this report, we present Atlas 2, Atlas 2-B, and Atlas 2-S, three pathology vision foundation models which bridge these shortcomings by showing state-of-the-art performance in prediction performance, robustness, and resource efficiency in a comprehensive evaluation across eighty public benchmarks. Our models were trained on the largest pathology foundation model dataset to date comprising 5.5 million histopathology whole slide images, collected from three medical institutions Charit√© - Universt√§tsmedizin Berlin, LMU Munich, and Mayo Clinic.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>